Nucleic acid and protein synthesis machinery of Plasmodium falciparum

The nucleic acid and protein synthesis machinery of Plasmodium falciparum erythrocytic stages refers to the collective enzymatic and ribosomal systems required for the parasite to replicate its genome and produce essential proteins during the blood stage of infection (Dahl & Rosenthal, 2007). This machinery is distributed across three distinct compartments: the nucleus, the mitochondria, and the apicoplast, a relict plastid essential for parasite survival (Wilson et al., 2015). During the erythrocytic cycle, the parasite undergoes intense metabolic activity and rapid division, making these biosynthetic pathways critical for survival and the progression of malaria symptoms (White, 2004). Therapeutic intervention often targets specific components of this machinery, such as the folate pathway for nucleotide synthesis or the prokaryotic-like ribosomes of the apicoplast (Gregson & Plowe, 2005). Drugs like pyrimethamine and doxycycline are classic examples that disrupt these processes to halt parasite proliferation. However, the complexity of these systems and the parasite's ability to develop resistance through genetic mutations in enzymes like dihydrofolate reductase (DHFR) present ongoing challenges for drug development (Gregson & Plowe, 2005).

Other names

Plasmodium falciparum replication and translation machineryMalaria parasite biosynthetic machineryPlasmodium falciparum protein synthesis system

Inhibition of dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) to block nucleic acid precursor synthesis, and inhibition of the 70S apicoplast ribosome to disrupt protein translation (Gregson & Plowe, 2005; Dahl & Rosenthal, 2007).